Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028
Go back to Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028| Puritan Financial Group, Inc. (AMEX: TNG) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $0.01 | 52 Week Low | $0.01 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $0.00 | |||
| Volume | 0 | |||||
